Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Prader-Willi Syndrome Association Will Help Promote Pharmacia Genotropin

Executive Summary

The national non-profit advocacy group Prader-Willi Syndrome Association will help promote Pharmacia's Genotropin for treatment of PWS by disseminating product information to its members.

You may also be interested in...

Pfizer Genotropin Adds Warning, Contraindication For Prader-Willi Patients

Pfizer Genotropin (somatropin) will be the only growth hormone in the U.S. to carry a warning regarding use in patients with Prader-Willi syndrome, despite FDA's belief that the potential associated adverse events are a class effect for growth hormone

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts